Skip to main content
Sisram Medical Ltd logo

Sisram Medical Ltd — Investor Relations & Filings

Ticker · 1696 ISIN · IL0011418113 HKEX Manufacturing
Open in API
Filings indexed 1,569 across all filing types
Latest filing 2024-09-05 AGM Information
Country HK Hong Kong
Listing HKEX 1696

About Sisram Medical Ltd

http://www.sisram-medical.com

Sisram Medical Ltd. is a global consumer wellness group specializing in medical aesthetics and minimally invasive solutions. Leveraging over two decades of expertise, the company is a leader in Energy-Based Devices (EBD), harnessing natural energy sources for both aesthetic and medical clinical indications. Sisram operates through a synergistic ecosystem of brands, providing medical-grade quality solutions to professional customers and consumers worldwide. Key segments include Alma, a provider of energy-based solutions for surgical and medical aesthetics markets; LMNT, a personal care brand for home use; Copulla, which offers end-to-end digital dentistry services; and a dedicated injectables portfolio. The company's extensive product range covers treatments such as hair removal, skin rejuvenation, body contouring, and dermal fillers.

Recent filings

Filing Released Lang Actions
(1) PROPOSED CAPITAL REORGANISATION&#x3b; (2) PROPOSED CHANGE IN BOARD LOT SIZE&#x3b; (3) ADJUSTMENT TO THE CONVERSION OF THE CPS&#x3b; (4) PROPOSED AMENDMENTS TO THE EXISTING BYE-LAWS&#x3b; (5) GENER
AGM Information Classification · 100% confidence The document is a circular from Reliance Global Holdings Limited related to an upcoming Annual General Meeting (AGM). It includes detailed information about proposed capital reorganisation, change in board lot size, amendments to bye-laws, general mandates to issue and repurchase shares, re-election of retiring directors, and the notice of the AGM itself. The document contains a notice convening the AGM, proxy form instructions, definitions, expected timetable, and a letter from the board. The content is typical of materials sent to shareholders ahead of an AGM to inform them of the agenda and proposals to be voted on. It is not a financial report, earnings release, or regulatory filing but rather the official circular and notice for the AGM. Therefore, the document fits the category of AGM Information (AGM-R). The document length (15,000 characters) and detailed content confirm it is the actual circular, not just an announcement of a report.
2024-09-05 English
GRANT OF RESTRICTED SHARE UNITS PURSUANT TO THE 2021 RSU SCHEME
Capital/Financing Update Classification · 95% confidence The document is an announcement from Sisram Medical Ltd regarding the grant of restricted share units (RSUs) pursuant to the 2021 RSU Scheme. It details the number of RSUs granted, the grantees, vesting period, performance targets, and other related information. The document is not a full financial report, earnings release, or management discussion, but rather a specific update on share-based compensation awards. It is also not a regulatory filing about voting results, board changes, or legal proceedings. The content fits the category of Capital/Financing Update (CAP) because it relates to the company's equity compensation plan and issuance of shares under that plan. The document length is about 5,459 characters, which is sufficient for a detailed announcement rather than a brief notice. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2024-09-04 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 August 2024
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 31 August 2024. It details movements in authorised/registered share capital, issued shares, treasury shares, convertibles, and confirms compliance with listing rules. It is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and share movement information for a specific month. It does not contain financial statements, earnings data, management discussion, or audit information. It is a regulatory filing reporting share capital movements and confirmations as required by listing rules, not a financial report or announcement of voting results or capital changes like new share issues or buybacks. Therefore, it fits best under Regulatory Filings (RNS). The document length (11,831 characters) and detailed data support this classification with high confidence.
2024-09-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024
Major Shareholding Notification Classification · 95% confidence The document is a detailed monthly report on movements in securities, specifically focusing on authorized share capital, issued shares, treasury shares, and related confirmations for Sisram Medical Ltd. It is submitted to the Hong Kong Exchanges and Clearing Limited and references compliance with Exchange Listing Rules. The content is regulatory in nature, reporting share capital and share movements, but it is not a financial report, earnings release, or management discussion. It is also not a simple announcement or a proxy solicitation. The document fits the category of a Major Shareholding Notification or related share capital movement report. Given the detailed share capital and share movement data, the best fitting category is Major Shareholding Notification (MRQ). The document length and detail support this classification with high confidence.
2024-09-03 English
VOLUNTARY ANNOUNCEMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Sisram Medical Ltd regarding the launch of a new product (Revanesse) in the U.K. market and a strategic partnership with Prollenium. It does not contain financial statements, detailed financial data, or regulatory filings such as annual or quarterly reports. The document is relatively short (2274 characters) and serves as a business update or corporate announcement rather than a formal financial or regulatory report. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is also not related to board changes, voting results, or capital changes. The content is best classified as a general regulatory announcement or miscellaneous corporate update, which falls under Regulatory Filings (RNS) as a fallback category for miscellaneous filings that do not fit other specific categories.
2024-09-02 English
(1) PROPOSED CAPITAL REORGANISATION&#x3b; (2) PROPOSED CHANGE IN BOARD LOT SIZE&#x3b; (3) ADJUSTMENT TO THE CONVERSION OF THE CPS&#x3b; AND (4) PROPOSED AMENDMENTS TO THE EXISTING BYE-LAWS
Capital/Financing Update Classification · 95% confidence The document is an announcement from Reliance Global Holdings Limited regarding a proposed capital reorganisation, change in board lot size, adjustment to conversion of convertible preference shares, and amendments to the company's bye-laws. It includes detailed descriptions of the proposed share consolidation, capital reduction, and related corporate actions. The document also mentions the upcoming Annual General Meeting (AGM) where these proposals will be considered and approved by shareholders. The content is focused on corporate actions related to capital structure and governance changes, not a full financial report or earnings release. It is not a proxy solicitation or voting results announcement, but rather a detailed announcement of proposed corporate actions requiring shareholder approval. This fits the category of Capital/Financing Update (CAP) as it deals with changes in capital structure and related corporate finance matters.
2024-09-01 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.